Credit Agricole SA Comments on Monsanto Co.’s FY2017 Earnings (MON)
Monsanto Co. (NYSE:MON) – Equities researchers at Credit Agricole SA dropped their FY2017 earnings estimates for Monsanto in a research note issued on Wednesday. Credit Agricole SA analyst M. Connelly now expects that the firm will post earnings per share of $4.80 for the year, down from their prior forecast of $4.94. Credit Agricole SA currently has a “Underperform” rating and a $110.00 price target on the stock. Credit Agricole SA also issued estimates for Monsanto’s FY2018 earnings at $5.72 EPS and FY2019 earnings at $6.81 EPS.
MON has been the topic of several other research reports. TheStreet lowered Monsanto from a “buy” rating to a “hold” rating in a research note on Monday, September 12th. Citigroup Inc. raised their price target on Monsanto from $112.00 to $116.00 and gave the company a “neutral” rating in a research note on Friday, August 19th. Monness Crespi & Hardt cut their price target on Monsanto from $130.00 to $128.00 and set a “buy” rating on the stock in a research note on Monday. BMO Capital Markets set a $128.00 target price on Monsanto and gave the company a “buy” rating in a research note on Thursday, September 15th. Finally, Goldman Sachs Group Inc. upgraded Monsanto from a “sell” rating to a “neutral” rating and set a $104.00 target price on the stock in a research note on Tuesday, September 27th. Three equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $114.67.
Monsanto (NYSE:MON) traded up 0.18% during midday trading on Friday, hitting $103.69. 1,245,915 shares of the stock traded hands. Monsanto has a 12 month low of $83.73 and a 12 month high of $114.26. The company has a 50-day moving average of $104.88 and a 200-day moving average of $101.34. The stock has a market cap of $45.37 billion, a PE ratio of 45.64 and a beta of 1.19.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/10/07/credit-agricole-sa-comments-on-monsanto-co-s-fy2017-earnings-mon.html
Monsanto (NYSE:MON) last released its quarterly earnings results on Wednesday, October 5th. The company reported $0.07 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.02) by $0.09. Monsanto had a net margin of 9.89% and a return on equity of 46.07%. The firm earned $2.56 billion during the quarter, compared to analyst estimates of $2.38 billion. During the same quarter in the prior year, the firm earned ($0.19) EPS. The business’s revenue for the quarter was up 8.8% compared to the same quarter last year.
Several hedge funds have recently modified their holdings of MON. FMR LLC boosted its stake in shares of Monsanto by 41.3% in the second quarter. FMR LLC now owns 16,593,757 shares of the company’s stock valued at $1,715,960,000 after buying an additional 4,851,499 shares during the last quarter. Third Point LLC purchased a new stake in shares of Monsanto during the second quarter valued at approximately $206,820,000. Carmignac Gestion purchased a new stake in shares of Monsanto during the second quarter valued at approximately $197,555,000. TIAA CREF Investment Management LLC boosted its stake in shares of Monsanto by 50.4% in the second quarter. TIAA CREF Investment Management LLC now owns 4,658,464 shares of the company’s stock valued at $481,732,000 after buying an additional 1,560,646 shares during the last quarter. Finally, Adage Capital Partners GP L.L.C. boosted its stake in shares of Monsanto by 205.6% in the second quarter. Adage Capital Partners GP L.L.C. now owns 1,705,121 shares of the company’s stock valued at $176,327,000 after buying an additional 1,147,200 shares during the last quarter. Hedge funds and other institutional investors own 79.02% of the company’s stock.
In related news, COO Brett D. Begemann sold 27,980 shares of the business’s stock in a transaction that occurred on Thursday, July 14th. The stock was sold at an average price of $103.62, for a total transaction of $2,899,287.60. Following the completion of the sale, the chief operating officer now directly owns 102,480 shares in the company, valued at $10,618,977.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Michael K. Stern sold 12,797 shares of the business’s stock in a transaction that occurred on Wednesday, July 13th. The stock was sold at an average price of $101.77, for a total value of $1,302,350.69. Following the sale, the chief executive officer now owns 21,583 shares of the company’s stock, valued at $2,196,501.91. The disclosure for this sale can be found here. Corporate insiders own 0.88% of the company’s stock.
The company also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Friday, October 7th will be given a dividend of $0.54 per share. This represents a $2.16 annualized dividend and a dividend yield of 2.09%. The ex-dividend date is Wednesday, October 5th. Monsanto’s payout ratio is 71.05%.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.